Controversies in the follow-up and management of well-differentiated thyroid cancer.

MD Ringel, PW Ladenson - Endocrine-Related Cancer, 2004 - erc.bioscientifica.com
Thyroid cancer is a common malignancy with an apparent increasing incidence and a wide
spectrum of clinical behavior and therapeutic responsiveness. Recent advances in …

Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis

MJ Dong, ZF Liu, K Zhao, LX Ruan… - Nuclear medicine …, 2009 - journals.lww.com
Aim The aim of this study was to evaluate the diagnostic accuracy of 18 F-
fluorodeoxyglucose-PET (FDG-PET) and FDG-PET/computed tomography (CT) in the …

Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer

RT Kloos - The Journal of Clinical Endocrinology & Metabolism, 2008 - academic.oup.com
The 10-yr survival of differentiated thyroid cancer is about 76–93%, and at least 10% of
patients manifest tumor persistence or recurrence, depending on their disease stage, after …

The role of TSH for 18F-FDG-PET in the diagnosis of recurrence and metastases of differentiated thyroid carcinoma with elevated thyroglobulin and negative scan: a …

C Ma, J Xie, Y Lou, Y Gao, S Zuo… - European journal of …, 2010 - academic.oup.com
Purpose To establish the effects of TSH stimulation on the uptake of fluorine-18-labeled 2-
fluoro-2-deoxy-d-glucose for differentiated thyroid carcinoma (DTC) with thyroglobulin …

Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)

M Dietlein, J Dressler, W Eschner… - Nuklearmedizin …, 2007 - thieme-connect.com
The procedure guideline for radioiodine therapy (RIT) of differentiated thyroid cancer
(version 3) is the counterpart to the procedure guideline for 131 I whole-body scintigraphy …

Better Yield of 18Fluorodeoxyglucose-Positron Emission Tomography in Patients with Metastatic Differentiated Thyroid Carcinoma during Thyrotropin Stimulation

KM van Tol, PL Jager, DA Piers, J Pruim, EGE de Vries… - Thyroid, 2002 - liebertpub.com
To determine whether 18fluorodeoxyglucose-positron emission tomography (FDG-PET) for
the detection of recurrences or metastases of differentiated thyroid carcinoma should be …

Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer

M Iwata, K Kasagi, T Misaki, K Matsumoto… - European journal of …, 2004 - Springer
The usefulness of fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography
(PET) in differentiated thyroid cancer (DTC) has been demonstrated by many investigators …

F-18 FDG PET/CT in the management of thyroid cancer

A Iagaru, JE Kalinyak, IR McDougall - Clinical Nuclear Medicine, 2007 - journals.lww.com
Purpose: There are approximately 32,000 new cases of thyroid carcinoma annually in the
United States. F-18 FDG PET/CT has an established role in cancer management, including …

[PDF][PDF] Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer

L Mansi, R Moncayo… - Quarterly …, 2004 - publicationslist.org.s3.amazonaws …
Diagnostic strategy in thyroid cancer is conditioned by epidemiological, pathophysiological,
cost-effective issues changing with age and countries. Nuclear medicine has a role mainly in …

[HTML][HTML] FDG-PET and PET/CT-Part II

AM Takalkar, G El-Haddad, DL Lilien - The Indian journal of …, 2008 - ncbi.nlm.nih.gov
The high diagnostic accuracy of FDG-PET and PET/CT has been well documented for
several neoplasms, with a consequent rapid increase in the utilization and acceptance of …